Praxis Precision Medicines, Inc. PRAX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s net change in cash?
- Praxis Precision Medicines, Inc. (PRAX) reported net change in cash of $179M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s net change in cash changed year-over-year?
- Praxis Precision Medicines, Inc.'s net change in cash increased by 459.4% year-over-year, from -$49.81M to $179M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s net change in cash?
- Over 2 years (2022 to 2025), Praxis Precision Medicines, Inc.'s net change in cash has grown at a 29.9% compound annual growth rate (CAGR), from -$84.09M to $141.96M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.